MedTrace Logo

Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's Disease

NCT00004826 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-03-25

No results posted yet for this study

Summary

OBJECTIVES: I. Determine the efficacy and tolerability of clozapine in ameliorating psychosis in patients with idiopathic Parkinson's disease (PD).

II. Determine the adverse effects of clozapine on motor function in this patient population.

III. Determine the safety of clozapine in psychotic PD patients taking multiple anti-PD medications.

IV. Describe the phenomenology of drug induced psychosis in PD.

Conditions

  • Parkinson Disease

Interventions

DRUG

clozapine

Sponsors & Collaborators

  • Memorial Hospital of Rhode Island

    lead OTHER

Principal Investigators

  • Joseph H. Friedman · Memorial Hospital of Rhode Island

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-10-31
Completion
1997-11-30

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004826 on ClinicalTrials.gov